Babak O Ia, Kushnir I E
Lik Sprava. 1996 Mar-Apr(3-4):123-5.
Overall thirty-six patients with gastric and duodenal ulcer were evaluated for the clinical effectiveness of ethonium. The results obtained showed sufficient effectiveness of this drug preparation in the therapy of the above medical conditions. The mild course of ulcer disease appears to be treatable by monotherapy, while moderately severe and severe courses require incorporation of other medicinal agents into therapeutic plans, specifically, those from the group of blockers H2-histaminic receptors. Ethonium is well tolerated by patients, side effects are rare and do not require special treatment, which facts allow it to be included into strategies for treating peptic ulcer.
总共对36例胃和十二指肠溃疡患者评估了乙磺半胱氨酸的临床疗效。所获得的结果表明该药物制剂在治疗上述病症方面具有足够的疗效。溃疡病的轻度病程似乎可用单一疗法治疗，而中度严重和重度病程则需要在治疗方案中加入其他药物，特别是H2组胺受体阻滞剂类药物。患者对乙磺半胱氨酸耐受性良好，副作用罕见且无需特殊治疗，这些事实使其可纳入消化性溃疡的治疗策略。
